Anti-idiotype vaccines to elicit catalytic antibodies

Details Anti-idiotype vaccines to elicit catalytic antibodies Anti-idiotype vaccines to elicit catalytic antibodies

1998-06-22

2000-10-31

Patterson, Jr., Charles L.

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Catalytic antibody

C12N 900

Patent

active

061400912

ABSTRACT:
Disclosed are methods for the production of second generation catalytic antibodies. The disclosed methods offer a variety of advantages relative to prior art techniques. For example, the methods of the present invention do not require prior identification of the active site of an enzyme, the activity of which is desired in the catalytic antibody. Additionally, the disclosed methods enable the production of antibodies which catalyze chemical reactions which do not occur in nature.

REFERENCES:
Lerner et al., Science 252: 659-667 (1991).
Benkovic, S.J., Annu. Rev. Biochem. 61: 29-54 (1992).
Izadyar et al., PNAS USA 90: 8876-8880 (1993).
Okuda et al., AIDS Research & Human Retroviruses 11: 933-943 (1995).
Stewart and Benkovic, Nature 375: 388-391 (1995).
Yang et al., J. of the Amer. Chem. Society 118: 5881 (1996).
Landry et al., Science 259: 1899 (1993).
Ghiara et al., Science 264: 82-85 (1994).
Pollack et al., Science 234: 1570-1573 (1986).
Avalle et al., The FASEB Journal 12: 1055-1060 (1998).
Friboulet, A., et al. (1994) App. Biochem. Biotechnol. 47, 229-239.
Avalle, B., et al. (1996) Ann. N.Y. Acad. Sci. 799, 172-175.
Hsu, K-H, et al. (1994) J. Agric. Food Chem. 42, 2343-2359.
Ban, N, et al. (1995) FASEB J. 9, 107-114.

Affiliated with

Also associated with

Rating

Anti-idiotype vaccines to elicit catalytic antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-idiotype vaccines to elicit catalytic antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-idiotype vaccines to elicit catalytic antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2050055